Article
Hypercholesterolemia-induced impairment in sorafenib functionality is overcome by avasimibe co-treatment
2024-03-28
Abstract excerpt
Avasimibe; a cholesterol-lowering drug with a proven safety in clinical trials, has recently been repositioned as an anticancer agent in various preclinical investigations. A study from our group reported that hypercholesterolemia promotes hepatocellular carcinoma (HCC) cell survival and hampers the anticancer effect of sorafenib, a kinase inhibitor. In the present study, we demonstrate that in HCC under hyperchol...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- ee358793-b7f6-5e4b-b3b5-eadef7afa276
- DOI
- 10.1101/2024.03.27.586757
